Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 39:1866-1873
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, H.-R.
Right arrow Articles by Fu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, H.-R.
Right arrow Articles by Fu, M.

EXPERIMENTAL STUDY

Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta1-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats

Hui-Rong Liu, MD, PhD*, Rong-Rui Zhao, MD, PhD*, Xiang-Ying Jiao, MD, PhD*, Ying-Yuan Wang, MD, PhD* and Michael Fu, MD, PhD{dagger},*

* Laboratory of Cardiovascular Physiology, Shanxi Medical University, Taiyuan, China
{dagger} Wallenberg Laboratory, Sahlgrenska University Hospital, Göteborg, Sweden

Manuscript received May 18, 2001; revised manuscript received February 13, 2002, accepted February 28, 2002.

* Reprint requests and correspondence: Prof. Rong-Rui Zhao, Lab of Cardiovascular Physiology, Shanxi Medical University, Taiyuan, China.

OBJECTIVES: We sought to investigate the mechanism responsible for the occurrence of anticardiac receptor autoantibodies.

BACKGROUND: Increasing evidence suggests the involvement of autoimmune mechanisms in the pathogenesis of a number of cardiovascular diseases. Among them, the biologic, functional and pathogenic properties of anticardiac receptor antibodies have been extensively investigated. However, the mechanism responsible for the occurrence of anticardiac receptor autoantibodies remains poorly understood.

METHODS: Two rat models (aortic banding [AB] and adriamycin [ADR] groups) were constructed. Determination of cardiac function and morphology and T-lymphocyte subtypes, enzyme-linked immunosorbent assay and cardiomyocyte cultures were performed.

RESULTS: It was shown, in the AB and ADR groups, that the frequency and titer of autoantibodies to beta1 and muscarinic type 2 receptors were increased when myocardial remodeling occurred, as evidenced by significant cardiac morphologic changes, deposition of collagen and obvious functional impairment. This suggests that cardiac remodeling itself, in two disparate models of heart failure and cardiomyopathy, was able to trigger the genesis of anticardiac receptor autoantibodies. These autoantibodies have biologic effects similar to those seen in human autoantibodies. They have also shown a characteristic self-growth, as well as a time-course decline, suggesting that a negative finding of anticardiac receptor autoantibodies in sera of patients with heart disease does not necessarily imply that there is no autoimmune reaction involved in the pathogenesis.

CONCLUSIONS: Our results demonstrated that myocardial damage was able to trigger the occurrence of an autoimmune reaction, resulting in the genesis of anticardiac receptor autoantibodies with properties similar to those seen in patients with idiopathic dilated cardiomyopathy.

Abbreviations and Acronyms
  AB
  aortic banding
  ADR
  adriamycin
  Bmax
  maximal number of receptor binding sites
  CD4+/CD8+
  ratio of helper to suppressor peripheral blood T lymphocytes
  CVF
  collagen volume fraction
  DCM
  dilated cardiomyopathy
  ±dP/dtmax
  maximal rate of rise and/or decline in left ventricular pressure
  ELISA
  enzyme-linked immunosorbent assay
  FITC
  fluorescein isothiocyanate
  LV
  left ventricle/ventricular
  Kd
  dissociation constant
  M2
  muscarinic type 2




This article has been cited by other articles:


Home page
CirculationHome page
B. Olshansky, H. N. Sabbah, P. J. Hauptman, and W. S. Colucci
Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy
Circulation, August 19, 2008; 118(8): 863 - 871.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Barth, R. Kuner, A. Buness, M. Ruschhaupt, S. Merk, L. Zwermann, S. Kaab, E. Kreuzer, G. Steinbeck, U. Mansmann, et al.
Identification of a Common Gene Expression Signature in Dilated Cardiomyopathy Across Independent Microarray Studies
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1610 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Ahokas, K. J. Warrington, I. C. Gerling, Y. Sun, L. A. Wodi, P. A. Herring, L. Lu, S. K. Bhattacharya, A. E. Postlethwaite, and K. T. Weber
Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface
Circ. Res., November 14, 2003; 93 (10): e124 - e135.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement